Gene variant effects across sodium channelopathies predict function and guide precision therapy.
Brain : A Journal Of Neurology
Brunklaus, Andreas A; Feng, Tony T; Brünger, Tobias T; Perez-Palma, Eduardo E; Heyne, Henrike H; Matthews, Emma E; Semsarian, Christopher C; Symonds, Joseph D JD; Zuberi, Sameer M SM; Lal, Dennis D; Schorge, Stephanie S
Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation.
Genome Research
Traynelis, Joshua J; Silk, Michael M; Wang, Quanli Q; Berkovic, Samuel F SF; Liu, Liping L; Ascher, David B DB; Balding, David J DJ; Petrovski, Slavé S
Publication Date: 2017-10
Variant appearance in text: SCN1A: 4033C>T; Pro1345Ser
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.
Nature Genetics
Carvill, Gemma L GL; Heavin, Sinéad B SB; Yendle, Simone C SC; McMahon, Jacinta M JM; O'Roak, Brian J BJ; Cook, Joseph J; Khan, Adiba A; Dorschner, Michael O MO; Weaver, Molly M; Calvert, Sophie S; Malone, Stephen S; Wallace, Geoffrey G; Stanley, Thorsten T; Bye, Ann M E AM; Bleasel, Andrew A; Howell, Katherine B KB; Kivity, Sara S; Mackay, Mark T MT; Rodriguez-Casero, Victoria V; Webster, Richard R; Korczyn, Amos A; Afawi, Zaid Z; Zelnick, Nathanel N; Lerman-Sagie, Tally T; Lev, Dorit D; Møller, Rikke S RS; Gill, Deepak D; Andrade, Danielle M DM; Freeman, Jeremy L JL; Sadleir, Lynette G LG; Shendure, Jay J; Berkovic, Samuel F SF; Scheffer, Ingrid E IE; Mefford, Heather C HC